Systolic Hypertension in Hemodialysis Patients

Seminars in Dialysis

Volumn 16, Issue 3, 2003, Pages 208-213

  Agarwal, Rajiv ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; LISINOPRIL; NITRENDIPINE; PERINDOPRIL; PLACEBO; RESERPINE;

AGING; BLOOD PRESSURE REGULATION; BLOOD VESSEL COMPLIANCE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; EXERCISE; HEMODIALYSIS; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PULSE PRESSURE; REVIEW; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TREATMENT OUTCOME; UREMIA; COMORBIDITY; EDITORIAL; KIDNEY DISEASE; RENAL REPLACEMENT THERAPY; SYSTOLE;

COMORBIDITY; HUMANS; HYPERTENSION; KIDNEY DISEASES; RENAL DIALYSIS; SYSTOLE;

EID: 0141672044     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2003.16041.x     Document Type: Review

References (64)

1. Izzo JL Jr, Levy D, Black HR: Clinical advisory statement. Importance of systolic blood pressure in older Americans. Hypertension 35:1021-1024, 2000
2. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32(suppl 3):S112-S119, 1998
3. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434-2439, 1999
4. McVeigh GE, Bratteli CW, Morgan DJ, Alinder CM, Glasser SP, Finkelstein SM, Cohn JN: Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis, aging and arterial compliance. Hypertension 33:1392-1398, 1999
5. O'Rourke MF: Wave travel and reflection in the arterial system. J Hypertens 17(suppl 5):S45-S47, 1999
6. van Bortel LM, Spek JJ: Influence of aging on arterial compliance. J Hum Hypertens 12:583-586, 1998
7. Black HR, Kuller LH, O'Rourke MF, Weber MA, Alderman MH, Benetos A, Burnett J, Cohn JN, Franklin SS, Mancia G, Safar M, Zanchetti A: The first report of the Systolic and Pulse Pressure (SYPP) Working Group. J Hypertens 17(suppl 5):S3-S14, 1999
8. Rostand SG, Brunzell JD, Cannon ROI, Victor RG: Cardiovascular complications in renal failure. J Am Soc Nephrol 2:1053-1062, 1991
9. Guerin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014-1021, 2000
10. Demuth K, Blacher J, Guerin AP, Benoit MO, Moatti N, Safar ME, London GM: Endothelin and cardiovascular remodelling in end-stage renal disease. Nephrol Dial Transplant 13:375-383, 1998
11. Converse RL Jr, Jacobsen TN, Toto RD, Jost CMT, Cosentino F, Fouad-Tarazi F, Victor RG: Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327:1912-1918, 1992
12. Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA: Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol 13:177-183, 2002
13. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Levy D: Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Hypertension 34:381-385, 1999
14. Hyman DJ, Pavlik VN: Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 345:479-486, 2001
15. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, Levy D: Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 103:1245-1249, 2001
16. Khattar RS, Swales JD, Dore C, Senior R, Lahiri A: Effect of aging on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation 104:783-789, 2001
17. Blacher J, Staessen JA, Girerd X, Gasowski J, Thijs L, Liu L, Wang JG, Fagard RH, Safar ME: Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 160:1085-1089, 2000
18. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ: Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 161:1207-1216, 2001
19. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
20. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001
21. Wright JT, Jr., Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288:2421-2431, 2002
22. Rocco MV, Yan G, Heyka RJ, Benz R, Cheung AK: Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO study. Am J Nephrol 21:280-288, 2001
23. Tozawa M, Iseki K, Iseki C, Oshiro S, Yamazato M, Higashiuesato Y, Tomiyama N, Tana T, Ikemiya Y, Takishita S: Evidence for elevated pulse pressure in patients on chronic hemodialysis: a case-control study. Kidney Int 62:2195-2201, 2002
24. Agarwal R, Lewis RR: Prediction of hypertension in chronic hemodialysis patients. Kidney Int 60:1982-1989, 2001
25. Tomita J, Kimura G, Inoue T, Inenaga T, Sanai T, Kawano Y, Nakamura S, Baba S, Matsuoka H, Omae T: Role of systolic blood pressure in determining prognosis of hemodialyzed patients. Am J Kidney Dis 25:405-412, 1995
26. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, Lazarus JM, Owen WF, Jr: Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287:1548-1555, 2002
27. Foley RN, Herzog CA, Collins AJ: Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 study. Kidney Int 62:1784-1790, 2002
28. Tozawa M, Iseki K, Iseki C, Takishita S: Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 61:717-726, 2002
29. Cruickshank JM: Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. BMJ 297(6658):1227-1230, 1988
30. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius, S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351(9118):1755-1762, 1998
31. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H, Zanchetti A: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 12:218-225, 2001
32. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 265:3255-3264, 1991
33. Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R: Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators [see comments]. N Engl J Med 340:677-684, 1999
34. Kjeldsen SE, Dahlof B, Devereux RB, Julius S, Aurup P, Edelman J, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn S, Wedel H: Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 288:1491-1498, 2002
35. Agarwal R: Assessment of blood pressure in hemodialysis patients. Semin Dial 15:299-304, 2002
36. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, III, Simons-Morton DG, Karanja N, Lin PH: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344:3-10, 2001
37. Chrysanthakopoulos SG, Kastagir BK, Jubiz W, Kolff WJ: Hypertension in patients on maintenance hemodialysis: evaluation of peripheral renin activity and bilateral nephrectomy. Am J Med Sci 264:9-21, 1972
38. Simon G, Jaeckel M, Illyes G: Altered structure and distensibility of arteries in salt-fed rats. J Hypertens 21:137-143, 2003
39. Miller BW, Cress CL, Johnson ME, Nichols DH, Schnitzler MA: Exercise during hemodialysis decreases the use of antihypertensive medications. Am J Kidney Dis 39:828-833, 2002
40. Charra B: "Dry weight" in dialysis: the history of a concept. Nephrol Dial Transplant 13:1882-1885, 1998
41. Chazot C, Charra B, Vo VC, Jean G, Vanel T, Calemard E, Terrat JC, Ruffet M, Laurent G: The Janus-faced aspect of "dry weight." Nephrol Dial Transplant 14:121-124, 1999
42. Lins RL, Elseviers M, Rogiers P, Van Hoeyweghen RJ, De Raedt H, Zachee P, Daelemans RA: Importance of volume factors in dialysis related hypertension. Clin Nephrol 48:29-33, 1997
43. Katzarski KS, Charra B, Luik AJ, Nisell J, Divino Filho JC, Leypoldt JK, Leunissen KM, Laurent G, Bergstrom J: Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 14:369-375, 1999
44. Weise F, London GM, Pannier BM, Guerin AP, Elghozi JL: Effect of hemodialysis on cardiovascular rhythms in end-stage renal failure. Kidney Int 47:1443-1452, 1995
45. Agarwal R: Strategies and feasibility of hypertension control in a prevalent hemodialysis cohort. Clin Nephrol 53:344-353, 2000
46. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL: Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation 90:2786-2796, 1994
47. Rahman M, Dixit A, Donley V, Gupta S, Hanslik T, Lacson E, Ogundipe A, Weigel K, Smith MC: Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis 33:498-506, 1999
48. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P: "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 54:561-569, 1998 [published erratum, Kidney Int 54:1417, 1998]
49. Salem MM: Hypertension in the haemodialysis population: any relationship to 2-years survival? Nephrol Dial Transplant 14:125-128, 1999
50. Agarwal R: Supervised atenolol therapy in management of hemodialysis hypertension. Kidney Int 55:1528-1535, 1999
51. Agarwal R, Lewis RR, Davis JL, Becker B: Lisinopril therapy for hemodialysis hypertension-hemodynamic and endocrine responses. Am J Kidney Dis 38:1245-1250, 2001
52. Efrati S, Zaidenstein R, Dishy V, Beberashvili I, Sharist M, Averbukh Z, Golik A, Weissgarten J: ACE inhibitors and survival of hemodialysis patients. Am J Kidney Dis 40:1023-1029, 2002
53. Zazgornik J, Biesenbach G, Forstenlehner M, Stummvoll K: Profile of antihypertensive drugs in hypertensive patients on renal replacement therapy (RRT). Clin Nephrol 48:337-340, 1997
54. London GM, Marchais SJ, Guerin AP, Metivier F, Safar ME, Fabiani F, Froment L: Salt and water retention and calcium blockade in uremia. Circulation 82:105-113, 1990
55. Marchais SJ, Boussac I, Guerin AP, Delavaux G, Metivier F, London GM: Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure. J Cardiovasc Pharmacol 18(suppl 5):S14-S18, 1991
56. Charra B: Control of blood pressure in long slow hemodialysis. Blood Purif 12:252-258, 1994
57. Charra B, Calemard E, Ruffet M, Chazot C, Terrat J-C, Vanel T, et al: Survival as an index of adequacy of dialysis. Kidney Int 41:1286-1291, 1992
58. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B, Pasticci F, Kaufman JM, Buoncristiani U: Short daily hemodialysis, blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 38:371-376, 2001
59. Kielstein JT, Boger RH, Bode-Boger SM, Schaffer J, Barbey M, Koch KM, Frolich JC: Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10:594-600, 1999
60. Friedman AN, Bostom AG, Levey AS, Rosenberg IH, Selhub J, Pierratos A: Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis. J Am Soc Nephrol 13:265-268, 2002
61. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM, Langos V, Uldall R: Nocturnal hemodialysis: three-year experience [see comments]. J Am Soc Nephrol 9:859-868, 1998
62. Hanly PJ, Pierratos A: Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 344:102-107, 2001
63. Chazot C, Charra B, Laurent G, Didier C, Vo VC, Terrat JC, Calemard E, Vanel T, Ruffet M: Interdialysis blood pressure control by long haemodialysis sessions. Nephrol Dial Transplant 10:831-837, 1995
64. McGregor DO, Buttimore AL, Nicholls MG, Lynn KL: Ambulatory blood pressure monitoring in patients receiving long, slow home haemodialysis. Nephrol Dial Transplant 14:2676-2679, 1999